Is the prognosis of small cell lung cancer good after chemotherapy? The prognosis is poor

Small cell lung cancer is highly malignant and has a poor prognosis. Small cell lung cancer is relatively sensitive to radiotherapy and chemotherapy. It is recommended to consider chemotherapy in a timely manner, and Chinese medicine anti-tumor treatment can also be used as an auxiliary.

The stronger the toxicity of chemotherapy drugs and the greater the dose of chemotherapy, the stronger the killing of tumor cells, but at the same time the greater the damage to the human body, including damage to the immune system and important organs. Radiotherapy often has the following complications: esophageal damage, lung damage, heart damage and myelitis. Therefore, it is best to use anti-radiation drugs such as ginsenoside Rh2 (life-protecting element) with a content of 16.2% during radiotherapy, which not only protects normal cells but also has the effect of killing cancer cells. To reduce the toxic side effects of radiotherapy and chemotherapy, you can consider taking the third-generation wall-removed Ganoderma lucidum spore powder. Ganoderma lucidum has been used in social applications for anti-radiation and chemotherapy for many years, but the market feedback is not the same, only because the conclusions of pharmacological research and social application are often separated by a distance of use method. In fact, the Ganoderma lucidum preparations used in pharmacological research are all highly concentrated Ganoderma lucidum preparations that have been extracted, while the Ganoderma lucidum products commonly seen in the market are mostly crudely processed (Ganoderma lucidum fruiting bodies or broken wall Ganoderma lucidum spore powder), which is far from the level of samples used in research.

Therefore, large-scale industrial extraction of effective ingredients from Ganoderma lucidum or using de-walled Ganoderma lucidum spore powder instead of broken Ganoderma lucidum spore powder is an optional approach.